CPhI & P-MEC India 2017

As the pharma industry is increasingly looking towards India for high quality, low cost pharma solutions, this event is the perfect place for companies to pick up on the latest trends and innovations the market has to offer. Meet the movers and shakers in India’s pharma machinery, technology and ingredients industry for a competitive advantage that will help grow your business.

Get a head start with CPhI and P-MEC India @ BKC

CPhI and P-MEC India will take place at two venues; BEC & BKC. The BKC venue will be opening one day earlier on November 27th.


Join us at CPhI & P-MEC BKC and be ahead to connect, network and interact with pharma professionals.
For your comfort, a complimentary shuttle bus service will be provided in between venues on the corresponding show days.

Opening Hours Exhibition: 

27 November 2017: 10:00 - 18:00 (BKC venue only)
28 November 2017: 10:00 - 18:00 (BEC & BKC venue)
29 November 2017: 10:00 - 18:00 (BEC & BKC venue)
30 November 2017: 10:00 - 18:00 (BEC venue only)

Why Visit

The Indian pharmaceutical market is growing at 13% annually, twice the world market growth rate. While its generics market is growing strong, it is also evolving into a cradle for new drugs. Simply put: as one of the strongest emerging markets in the global pharma industry, India presents great opportunities for all international pharmaceutical companies to explore and benefit from.

CPhI India represent the platform where international and domestic pharma experts meet to do business, network and shape the future of the Indian and South East Asian pharmaceutical industry.

Key reasons to attend CPhI India:

• Meet the biggest representation of pharma ingredients manufacturers in one single location
• Source high quality products at the most competitive price
• Network and do business with over 50,000 experts from 120+ countries
• Grow your client range and establish new business relationships
• Learn about the latest trends and developments via onsite conferences, seminars, showcase rooms and more.